Need Help?
Copied to clipboard!

IMMUcan DEDICATION NSCLC3 cohort

The goal of IMMUcan is to understand how the immune system interacts with tumors and how therapeutic interventions influence this interaction. This cohort focuses on research into the treatment of patients with non-small cell lung cancer with the immunotherapy drug pembrolizumab. Research is being done into whether this drug can be given in a lower dosage and more individually tailored. Dedication-1 study (NVALT 30) (Non-small cell lung cancer) Comprehensive profiling data are integrated with longitudinally collected clinical information. Cellular profiling of the same tumor samples was performed using multiplex immunofluorescence imaging, imaging mass cytometry, and H&E staining.

Cite

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD50000003024 Illumina Genome Analyzer II 222
EGAD50000003025 Illumina Genome Analyzer II 111